Dupilumab efficacy in eosinophilic esophagitis persists for histologic, symptomatic, and endoscopic outcomes regardless of concomitant high-dose proton pump inhibitor use

被引：0

作者：

Rothenberg, Marc E. ^{[1
,2
]}

Schoepfer, Alain ^{[3
]}

Dellon, Evan S. ^{[4
]}

Bredenoord, Albert J. ^{[5
]}

Martire, Erika ^{[6
]}

Sun, Xian ^{[7
]}

Laws, Elizabeth

Mortensen, Eric ^{[7
]}

Maloney, Jennifer ^{[7
]}

Glotfelty, Lila ^{[8
]}

Shabbir, Arsalan ^{[7
]}

机构：

[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[3] CHU Vaudois, Lausanne, Switzerland

[4] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[5] Acad Med Ctr, Amsterdam, Netherlands

[6] Sanofi, Mississauga, ON, Canada

[7] Regeneron Pharmaceut Inc, Tarrytown, NV USA

[8] Sanofi, Bridgewater, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：29S / 31S

页数：3

共 23 条